Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01)

This grant encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective open- and closed-loop glucose control systems.  Proposed research should tackle important obstacles at the level of sensing, hormone formulation and delivery, self-management decision support systems, and/or design of automated controllers/algorithms able to manage an integrated platform. 

Funding: $500,000 per year 

Duration: 4 years 

Research Authority due date: 27.3.18

LOI (encouraged) due date: 10.4.18

Full application due date: 10.5.18